Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology Share page: Docket Number: FDA-2010-D-0530 CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials. Download Document Issues: OTC Medicines Sunscreen Other Issues Quality Related Posts Articles Polibrief: Post-Consumer Recycled Content Jul 9, 2024 Press Releases and Statements CHPA Statement on U.S. Supreme Court Overturning the Chevron Standard Jun 28, 2024 Press Releases and Statements CHPA Welcomes New Board Members at June Meeting Jun 14, 2024